| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2023/11/30 | 21 : 30 | Edgar (US Regulatory) | Form 15-12G - Securities registration termination [Section 12(g)] | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 2023/11/27 | 14 : 15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 2023/11/27 | 14 : 15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 2023/11/21 | 07 : 09 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 2023/11/21 | 07 : 07 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 2023/11/21 | 07 : 05 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 2023/11/21 | 07 : 03 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 2023/11/21 | 07 : 03 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 2023/11/21 | 07 : 01 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 2023/11/21 | 06 : 51 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 2023/11/21 | 06 : 43 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 2023/11/21 | 06 : 42 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 2023/11/21 | 06 : 41 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 2023/11/21 | 06 : 41 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 2023/11/21 | 06 : 40 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 2023/11/21 | 06 : 39 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 2023/11/21 | 06 : 39 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 2023/11/21 | 06 : 38 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 2023/11/21 | 06 : 38 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 2023/11/21 | 06 : 37 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 2023/11/21 | 06 : 37 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 2023/11/21 | 06 : 35 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 2023/11/21 | 06 : 32 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 2023/11/21 | 06 : 31 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 2023/11/21 | 06 : 26 | Edgar (US Regulatory) | Form 8-K - Current report | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 2023/11/20 | 22 : 49 | Edgar (US Regulatory) | Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 2023/11/14 | 20 : 04 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 2020/01/04 | 06 : 20 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 2020/01/04 | 06 : 17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 2020/01/04 | 06 : 14 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | USOTC:ACER | Acer Therapeutics Inc (PK) |